Feasibility of a Home Exercise Program With the Addition of a Corticosteroid Injection in Patients With Lateral Hip Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35+
SponsorAalborg University

About this trial

We have developed an exercise protocol that we plan to evaluate in a future randomized controlled trial in combination with a corticosteroid injection. In accordance with the MRC Framework of Complex Interventions, which reccomends stepwise development of interventions and testing of feasibility before applying them to a trial, we aim to evaluate the feasibility of our intervention before initiating further trials.

The purpose of this non-randomized feasibility study is to test the feasibility and acceptability of this exercise protocol with addition of a corticosteroid injection with no aim of evaluating effects.

All participants in this study will receive the following interventions:

* An ultrasound-guided corticosteroid injection superficial to the insertion of the gluteus medius and minimus tendons on the greater trochanter of the hip. * A home exercise program including 3 exercises, scalable to 3 different difficulty levels. * A patient information leaflet containing relevant information on managing lateral hip pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

35 years of age

Self-reported pain on the outside of the hip for at least 12 weeks with an average intensity of present pain over the last week of at least 4/10 on a numeric rating scale 0-10 (0 being no hip pain and 10 being worst hip pain imaginable)

Access to a computer, smartphone or tablet with internet connection

Tenderness on palpation of the greater trochanter

Disqualifiers

Corticosteroid injection in the affected hip or other new treatment by a health professional within the last 3 months

History of systemic inflammatory diseases, e.g. rheumatoid arthritis, spondyloarthritis

Weekly intake of oral glucocorticoids

History of other hip conditions, e.g. clinically significant hip osteoarthritis, hip dysplasia, prior hip surgery

Trial design

Design model

Single group

Treatments tested in this trial

  • Ultrasound-guided corticosteroid injection

    Drug

    Participants will receive one ultrasound-guided injection with 1 ml Kenalog 40mg/ml and 1 ml Lidocaine 10mg/ml superficial to the insertion of the gluteus medius and minimus tendons on the greater trochanter of the hip at baseline, Prior to the beginning of exercises.

  • Home exercise program

    Behavioral

    Our exercise protocol is based on previous literature and expert opinions that has been synthesized in a Delphi study conducted by our research group. The exercise program consists of three body weighted strength exercises, that are to be performed every second day for a period of eight weeks (see appendix 6, "Træningsvejledning"). Exercise instructions will be available as a handout and online with video instructions. The corticosteroid injection usually causes a flare-up in pain with a duration of up to 48 hours. Participants will be instructed to begin the exercises as soon as possible after this flare-up has settled. Compliance to exercises are measured using a training diary that the participants must fill out during the study period (see appendix 7, "Træningsdagbog").

  • Patient information leaflet

    Behavioral

    In order to support self-management and modification of tendon load, participants will receive a handout at baseline that contains information about GTPS and advice on load management (see appendix 8, "Folder - Smerter på ydersiden af hoften"). The participants will be encouraged to read the leaflet regularly and follow the advice.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Home Exercise Program With the Addition of a Corticosteroid InjectionExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Acceptability of performing our exercise program

This outcomes will be evaluated by asking the participants the following question "How acceptable was it for you to perform the exercise program?". This will be answered using a 7-point Likert scale ranging from "very unacceptable" to "very acceptable". The responses will be dichotomized as either "unacceptable" (category 1-4) or "acceptable" (category 5-7). Participants will be asked to elaborate their responses in a text field. Compliance to exercises will be measured using a training diary.

Time frame
8-week follow-up
2

Acceptability of performing exercises after receiving a corticosteroid injection

This outcome will be evaluated by asking the participants the question "How acceptable was it for you to start doing exercises shortly after receiving a corticosteroid injection?". This will be answered using a 7-point Likert scale ranging from "very unacceptable" to "very acceptable". The responses will be dichotomized as either "unacceptable" (category 1-4) or "acceptable" (category 5-7). Participants will be asked to elaborate their responses in a text field.

Time frame
8-week follow-up
3

Feasibility of the Home exercise program with the addition of a corticosteroid injection

To conclude that the combined treatments are feasible, ≥ 75% of patients must rate the treatment as 'acceptable'. If any participant drops out after the injection, they will be dichotomized as "not acceptable". A minimum of 15/20 training diaries must be handed in at 8-weeks follow-up. Based on the returned training diaries, ≥ 75% of participants need to complete ≥ 20/28 possible training sessions. A training session will be considered completed if the participant has performed at least one set of each exercise.

Time frame
8-week follow-up

Secondary outcomes

1

Exercise motivation

Exercise motivation is assessed using a 5-point Likert scale

Time frame
Baseline
2

Global rating of change (GROC)

GROC is determined by asking the question "How is your lateral hip pain now compared to when you first came in for treatment in this project?", which will be responded to with a 7-point Likert scale ranging from "very much worse" to "very much better".

Time frame
8-week follow-up
3

Patient Acceptable Symptom State (PASS)

PASS will be identified by asking the patient to answer yes or no to the question "Is your lateral hip pain at an acceptable level that does not require any further treatment?" Average of present lateral hip pain intensity over the last week on a numeric rating scale 0-10

Time frame
8-weeks follow-up
4

VISA-G

Question 1 receives a VAS rating of 0 to 10. (10 is optimal health) The 5 categories on questions 2 through 6 can be scored as 0, 2, 5, 7, or 10. The 4 categories on question 7 can be scored as 0, 4, 7, or 10. Question 8 is graded according to how long the patient can train in spite of their current level of pain. The maximum score for an asymptomatic person is 100; the smallest score is 0

Time frame
Baseline, 4-weeks and 8-weeks follow-up

Other outcomes

1

Qualitative outcomes

Qualitative data will be obtained via interviews at 4- and 8-week follow-up, in order to get feedback that will help us refine our exercise intervention before we apply it in a larger trial. The interviews will be recorded and transcribed.

Time frame
4-week and 8-week follow-up

Sponsors and contacts

Click on the lead sponsor to view all of their trials.